ENDRA Life Sciences (NDRA) Net Cash Flow Growth (1y) (2017 - 2026)
Powered by 
Analysis
ENDRA Life Sciences (NDRA) Net Cash Flow Growth (1y) (2017 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | GE HealthCare Technologies | 28.97 Bn | 27.09 Bn | 2.18 Bn | -114.85% |
| 2 | Lantheus Holdings | 6.56 Bn | 5.97 Bn | 241.86 Mn | 138.84% |
| 3 | Heartflow | 4.40 Bn | 4.03 Bn | 53.19 Mn | - |
| 4 | Neogen | 2.83 Bn | 2.64 Bn | 107.80 Mn | 1,718.75% |
| 5 | Butterfly Network | 1.88 Bn | 1.75 Bn | 23.29 Mn | -87.89% |
| 6 | Ceribell | 931.50 Mn | 802.24 Mn | 25.94 Mn | 88.88% |
| 7 | Varex Imaging | 779.32 Mn | 694.02 Mn | 76.70 Mn | 106.95% |
| 8 | Anbio Biotechnology | 755.43 Mn | 743.53 Mn | - | - |
| 9 | QuidelOrtho | 725.35 Mn | 601.95 Mn | - | -173.62% |
| 10 | ENDRA Life Sciences | 8.25 Mn | 2.71 Mn | - | 2,122.43% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 2,122.43% |
| Mar 31, 2026 | 65.15% |
| Dec 31, 2025 | 97.91% |
| Sep 30, 2025 | 38.72% |
| Jun 30, 2025 | -104.87% |
| Mar 31, 2025 | 31.46% |
| Dec 31, 2024 | -202.76% |
| Sep 30, 2024 | -11.49% |
| Jun 30, 2024 | 113.70% |
| Mar 31, 2024 | 32.94% |
| Dec 31, 2023 | 83.99% |
| Sep 30, 2023 | 54.47% |
| Jun 30, 2023 | -40.63% |
| Mar 31, 2023 | -8.55% |
| Dec 31, 2022 | -34.12% |
| Sep 30, 2022 | -44.95% |
| Jun 30, 2022 | 248.27% |
| Mar 31, 2022 | -124.28% |
| Dec 31, 2021 | -167.90% |
| Sep 30, 2021 | -173.90% |